Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,762.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (0.17%)
Market Cap: £1.97b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Refinancing

1 Oct 2013 09:58

RNS Number : 3878P
Derwent London PLC
01 October 2013
 



1 October 2013

 

Derwent London signs new £550m five year unsecured bank facility

 

Derwent London ("Derwent London plc"/ "the Group") announces today that it has signed a new £550m unsecured five year revolving credit facility.

 

The new facility is being provided by the Group's principal relationship banks, HSBC, RBS, Barclays and Lloyds, with HSBC as agent. It replaces £650m of secured bank facilities expiring between April 2014 and January 2017, as was indicated in the Group's interim results announced in August and follows on from the Group's issue in July of £150m of convertible bonds due in July 2019.

 

The margin payable under the new facility is 160 basis points over LIBOR for net asset gearing levels of up to 50%. The margin increases at higher levels of gearing with a maximum permitted level of 160%. The current level of Group net asset gearing is 40.4% based on June 2013 property values.

 

Damian Wisniewski, Finance Director of Derwent London, commented:

 

"Our new unsecured bank facility brings greater operational flexibility in relation to individual properties and the release of security on the facilities repaid provides the Group with a pool of unencumbered assets of over £1.8bn. We are pleased to have put these new arrangements in place at competitive pricing."

 

-ends-

 

 

For further information please contact:

 

Derwent London 020 7659 3000

 

Damian Wisniewski, Finance Director

 

Louise Rich, Head of Investor Relations

 

 

Brunswick Group 020 7404 5959

 

Elizabeth Adams

 

Sheena Shah

 

 

 

Notes to editors

 

Derwent London

 

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £3.1bn as at 30 June 2013, making us the largest London-focused real estate investment trust (REIT).

Our experienced team has a proven record of value creation through development, refurbishment and asset management activities. We take a fresh approach to each building, adopting a design-led and tenant-led philosophy. We focus on buildings with reversionary mid-market rents, particularly those in improving locations around the West End and the City borders.

The business is grounded on a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our portfolio of 5.5 million sq ft (510,600m2) as at 30 June 2013 include Angel Building EC1, The Buckley Building EC1, Qube W1, Horseferry House SW1 and Tea Building E1.

In 2013 to date Derwent London has won the 'West End Deal of the Year' for our letting to Burberry at 1 Page Street SW1 and 'City Development of the Year' for our 4 & 10 Pentonville Road N1 scheme at the OAS Development Awards as well as 'Developer of the Year' at the New Energy & Cleantech Awards. In addition the 2012 Report & Accounts and 2012 Sustainability Report have been awarded an EPRA Gold award

Derwent London came seventh overall in the 2012 Management Today awards for 'Britain's Most Admired Companies', topping the real estate sector for the third year in a row. Earlier in 2012 the Group won the Estates Gazette 'Property Company of the Year - Offices' award. Last year the Tea Building also won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPEFESKDFEF
Date   Source Headline
30th Jun 20083:15 pmRNSDirector/PDMR Shareholding
30th Jun 20083:15 pmRNSDirector/PDMR Shareholding
30th Jun 20082:56 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
30th Jun 20082:55 pmRNSDirector/PDMR Shareholding
23rd Jun 20084:54 pmRNSDirector/PDMR Shareholding
23rd Jun 20084:53 pmRNSDirector/PDMR Shareholding
12th Jun 20084:30 pmRNSDirector/PDMR Shareholding
30th May 20085:05 pmRNSHolding(s) in Company
30th May 20084:56 pmRNSHolding(s) in Company
19th May 20083:30 pmRNSHolding(s) in Company
19th May 200811:30 amRNSAnnual Information Update
19th May 20087:00 amRNSInterim Management Statement
13th May 200812:26 pmRNSNotice of IMS
13th May 200812:26 pmRNSNotice of IMS
28th Apr 20083:30 pmRNSBlocklisting Interim Review
23rd Apr 20084:50 pmRNSDocuments re Annual Report
18th Mar 20087:02 amRNSFinal Results
29th Feb 20087:01 amRNSPlanning Consent
21st Feb 200812:22 pmRNSNotice of Results
13th Feb 20089:20 amRNSPlanning permission
12th Feb 200810:19 amRNSTransfer of Bond listing
31st Jan 20084:45 pmRNSHolding(s) in Company
21st Jan 200811:15 amRNSHolding(s) in Company
21st Jan 200810:00 amRNSPlanning consent received
10th Jan 20081:45 pmRNSDirector/PDMR Shareholding
8th Jan 20088:00 amRNSRe: Letting
4th Jan 20089:00 amRNSDirectorate Change
2nd Jan 20084:21 pmRNSTotal Voting Rights
31st Dec 200711:30 amRNSDirector/PDMR Shareholding
21st Dec 20073:15 pmRNSDirector/PDMR Shareholding
30th Nov 20079:45 amRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20072:00 pmRNSDirector/PDMR Shareholding
5th Nov 20075:45 pmRNSBlocklisting Interim Review
5th Nov 20073:30 pmRNSHolding(s) in Company
24th Sep 200711:00 amRNSDoc re. Interim Report
20th Sep 20078:30 amRNSDirector/PDMR Shareholding
11th Sep 20077:02 amRNSInterim Results
16th Aug 200711:03 amRNSAnnual Information Update
16th Aug 20077:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.